Email - info@lenusoncology.com
Male breast cancer is a rare form of cancer that develops in the breast tissue of men. Although it is much less common than breast cancer in women, it is important to be aware of its existence.
Types of Male Breast Cancer:
– Ductal Carcinoma: Ductal carcinoma is the most common type of male breast cancer. It originates in the cells lining the milk ducts within the breast.
– Lobular Carcinoma: Lobular carcinoma, which begins in the milk-producing glands (lobules) of the breast, is less common in men than in women.
Age: The risk of male breast cancer increases with age, particularly after the age of 60.
Family History: Having a family history of breast cancer, especially in close relatives like a mother, sister, or daughter, increases the risk.
Genetic Mutations: Mutations in the BRCA1 and BRCA2 genes, which are also associated with an increased risk of female breast cancer, can increase the risk of male breast cancer as well.
Radiation Exposure: Prior radiation therapy to the chest, such as for the treatment of Hodgkin lymphoma, can increase the risk.
Hormonal Factors: Conditions that alter hormone levels, such as Klinefelter syndrome, liver disease, obesity, or estrogen treatments, may increase the risk of male breast cancer.
Family Cancer Syndromes: Certain inherited cancer syndromes, such as Li-Fraumeni syndrome or Cowden syndrome, can increase the risk of male breast cancer.
Clinical Examination: A healthcare professional will perform a physical examination of the breast and surrounding areas to check for lumps, changes in size or shape, or any other abnormalities.
Imaging Tests: Mammography and ultrasound may be used to evaluate the breast tissue and detect any abnormalities.
Biopsy: A biopsy is performed to confirm the presence of cancer cells. It involves the removal of a small sample of breast tissue for laboratory analysis.
Pathological Analysis: The biopsy sample is analyzed by a pathologist to determine the type, stage, and characteristics of the cancer cells.
Surgery: The primary treatment for male breast cancer is typically surgery, which may involve a mastectomy (removal of the entire breast) or a lumpectomy (removal of the tumor and a portion of surrounding tissue).
Radiation Therapy: Radiation therapy may be recommended after surgery to destroy any remaining cancer cells and reduce the risk of recurrence.
Chemotherapy: Chemotherapy drugs may be used to kill cancer cells or reduce the risk of recurrence. It may be administered before or after surgery.
Hormone Therapy: Male breast cancer is often hormone receptor-positive, meaning the cancer cells have receptors for hormones like estrogen or progesterone. Hormone therapy, such as tamoxifen or aromatase inhibitors, may be used to block the effects of these hormones and prevent cancer growth.
Targeted Therapy: In some cases, targeted therapy drugs that specifically target certain genetic mutations or cellular receptors may be used.
The treatment plan for male breast cancer is determined based on the individual’s specific situation, including the stage of cancer, overall health, and presence of any genetic mutations. Regular follow-up and monitoring are crucial to detect any signs of recurrence or new cancer development. Awareness, early detection, and timely treatment are key factors in improving outcomes for male breast cancer patients.